Sanofi aims to expand in diabetes market

PARIS (Reuters) - Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but al…
Read the full story: Reuters: Health News